EMCN and neoplasm: As NRP1flflNRP2flfl.ECKO tumor vessels exhibited significantly reduced EDA-FN outgrowth, we subsequently assessed pericyte coverage by co-immunolabeling NG2+ mural cells with endomucin+ blood vessels (48).